Treatment
Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 clinical trials
We’re tracking 2 recruiting studies that include Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1, each written for real people, not researchers, below.
Recruiting studies
- NCT05477849RecruitingPhase 1
Study drug for people with advanced solid tumors
This Phase 1 trial tests the safety and early effects of VG2025 in people with advanced solid cancers that have stopped responding to standard treatments. It’s mainly looking for side effects and how the body processes the drug, and it may offer a new option when other treatments haven’t worked.
Hangzhou, ZhejiangAges 18–75 - NCT07262164RecruitingPhase 1
Testing VG2062 for advanced solid tumors
This trial is testing a new drug called VG2062 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how the body processes it.
HebeiAges 18–75
What Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 is being studied for
Conditions with recruiting Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 studies.
Common questions
- Are there clinical trials studying Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1?
- Yes. Clin2 currently lists 2 recruiting studies that include Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 or a specific trial is right for you.
Related treatments
- Recombinant Human Growth Hormone
- Recombinant Human Adenovirus Type 5
- Recombinant human erythropoietin
- Human Umbilical Cord Mesenchymal Stem Cells
- Recombinant Granulocyte Colony-Stimulating Factor
- Recombinant Respiratory Syncytial Virus Vaccine
- Dual-target CAR-NK cells
- Human albumin
- Human Dopaminergic Progenitor Cells
- Dual antiplatelet therapy
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.